| |
| |
| Introduction to the FASTtrack series | |
| |
| |
| Preface | |
| |
| |
| About the author | |
| |
| |
| |
| Pharmaceutical solutions for oral administration | |
| |
| |
| General description | |
| |
| |
| Advantages and disadvantages of pharmaceutical solutions for oral administration | |
| |
| |
| Drug solubility | |
| |
| |
| Excipients used in pharmaceutical solutions for oral administration | |
| |
| |
| Types of pharmaceutical solutions | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Pharmaceutical disperse systems 1: suspensions - general principles and the formulation of suspensions for oral administration | |
| |
| |
| General description | |
| |
| |
| Advantages and disadvantages of pharmaceutical suspensions | |
| |
| |
| The physical stability of pharmaceutical suspensions | |
| |
| |
| Formulation considerations for orally administered suspension formulations | |
| |
| |
| Excipients used in the formulation of suspensions for oral administration | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Pharmaceutical disperse systems 2: emulsions and creams | |
| |
| |
| General description | |
| |
| |
| Advantages and disadvantages of pharmaceutical emulsions | |
| |
| |
| Emulsion instability and theories of emulsification | |
| |
| |
| Formulation of pharmaceutical emulsions | |
| |
| |
| Excipients used in pharmaceutical emulsions | |
| |
| |
| Manufacture of emulsions | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Pharmaceutical disperse systems 3: ointments, pastes, lotions, gels and related formulations | |
| |
| |
| Introduction | |
| |
| |
| Advantages and disadvantages of pharmaceutical ointments, pastes, lotions, liniments, collodions and gels | |
| |
| |
| Pharmaceutical ointments and pastes | |
| |
| |
| Pharmaceutical lotions, liniments, collodions and paints | |
| |
| |
| Pharmaceutical gels | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Parenteral formulations | |
| |
| |
| General description | |
| |
| |
| Routes of parenteral administration | |
| |
| |
| Advantages and disadvantages of parenteral formulations | |
| |
| |
| Formulation considerations for parenteral formulations | |
| |
| |
| Surface-active agents | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Ocular, nasal and otic dosage forms | |
| |
| |
| Introduction | |
| |
| |
| Advantages and disadvantages of ocular dosage forms | |
| |
| |
| Administration of therapeutic agents to the eye | |
| |
| |
| Nasal formulations | |
| |
| |
| Otic formulations | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Vaginal and rectal dosage forms | |
| |
| |
| Introduction | |
| |
| |
| Rectal dosage forms | |
| |
| |
| Vaginal dosage forms | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Respiratory dosage forms | |
| |
| |
| Introduction | |
| |
| |
| Advantages and disadvantages of respiratory drug delivery | |
| |
| |
| Physiology of the respiratory tract | |
| |
| |
| Factors affecting the deposition of particles/droplets within the respiratory tract | |
| |
| |
| Mechanisms of particle deposition within the respiratory tract | |
| |
| |
| Formulation of respiratory dosage forms | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Solid-dosage forms 1: tablets | |
| |
| |
| Introduction | |
| |
| |
| Advantages and disadvantages of tablets as dosage forms | |
| |
| |
| Manufacture of tablets | |
| |
| |
| Tablet defects | |
| |
| |
| Postprocessing effects on tablet properties | |
| |
| |
| Coating of tablets | |
| |
| |
| Multiple choice questions | |
| |
| |
| |
| Solid-dosage forms 2: capsules | |
| |
| |
| Introduction | |
| |
| |
| Advantages and disadvantages of capsule formulations | |
| |
| |
| Materials and manufacture of capsules | |
| |
| |
| Formulation considerations for hard gelatin capsules | |
| |
| |
| Soft gelatin capsules | |
| |
| |
| Multiple choice questions | |
| |
| |
| Multiple choice answers | |
| |
| |
| Index | |